AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $45,000,000 | +1476.7% | 752,003 | +640.0% | 0.02% | +1500.0% |
| Q3 2019 | $2,854,000 | +117.4% | 101,618 | +193.0% | 0.00% | 0.0% |
| Q2 2019 | $1,313,000 | +18.1% | 34,680 | +21.7% | 0.00% | – |
| Q1 2019 | $1,112,000 | -59.1% | 28,500 | -77.6% | 0.00% | -100.0% |
| Q4 2018 | $2,718,000 | +676.6% | 127,490 | +1343.8% | 0.00% | – |
| Q3 2018 | $350,000 | -3.8% | 8,830 | -7.1% | 0.00% | – |
| Q2 2018 | $364,000 | -76.0% | 9,508 | -81.2% | 0.00% | -100.0% |
| Q1 2018 | $1,518,000 | +450.0% | 50,532 | +471.9% | 0.00% | – |
| Q4 2017 | $276,000 | +26.0% | 8,836 | +13.1% | 0.00% | – |
| Q3 2017 | $219,000 | +1890.9% | 7,816 | +1209.2% | 0.00% | – |
| Q2 2017 | $11,000 | – | 597 | +3411.8% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 17 | -98.8% | 0.00% | – |
| Q3 2016 | $25,000 | – | 1,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |